Page last updated: 2024-10-19

phosphorylcholine and Neoplasms, Pleural

phosphorylcholine has been researched along with Neoplasms, Pleural in 2 studies

Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.

Research Excerpts

ExcerptRelevanceReference
"We tested Perifosine activity on human mesothelial cells and different mesothelioma cell lines, in order to provide evidence of its efficacy as single agent and combined therapy."7.78Perifosine as a potential novel anti-cancer agent inhibits EGFR/MET-AKT axis in malignant pleural mesothelioma. ( Angeli, G; Manente, AG; Moro, L; Mutti, L; Pinton, G, 2012)
"We tested Perifosine activity on human mesothelial cells and different mesothelioma cell lines, in order to provide evidence of its efficacy as single agent and combined therapy."3.78Perifosine as a potential novel anti-cancer agent inhibits EGFR/MET-AKT axis in malignant pleural mesothelioma. ( Angeli, G; Manente, AG; Moro, L; Mutti, L; Pinton, G, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamaji, M1
Ota, A1
Wahiduzzaman, M1
Karnan, S1
Hyodo, T1
Konishi, H1
Tsuzuki, S1
Hosokawa, Y1
Haniuda, M1
Pinton, G1
Manente, AG1
Angeli, G1
Mutti, L1
Moro, L1

Other Studies

2 other studies available for phosphorylcholine and Neoplasms, Pleural

ArticleYear
Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells.
    Cancer medicine, 2017, Volume: 6, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Benzylamines; Caspase 3; Caspase 7; Cell Line, Tumor; Cyclin-Depen

2017
Perifosine as a potential novel anti-cancer agent inhibits EGFR/MET-AKT axis in malignant pleural mesothelioma.
    PloS one, 2012, Volume: 7, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cisplatin;

2012